1-207090484-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001017365.3(C4BPB):​c.232+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.491 in 1,597,846 control chromosomes in the GnomAD database, including 201,497 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 14676 hom., cov: 32)
Exomes 𝑓: 0.50 ( 186821 hom. )

Consequence

C4BPB
NM_001017365.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0008636
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.506

Publications

19 publications found
Variant links:
Genes affected
C4BPB (HGNC:1328): (complement component 4 binding protein beta) This gene encodes a member of a superfamily of proteins composed predominantly of tandemly arrayed short consensus repeats of approximately 60 amino acids. A single, unique beta-chain encoded by this gene assembles with seven identical alpha-chains into the predominant isoform of C4b-binding protein, a multimeric protein that controls activation of the complement cascade through the classical pathway. C4b-binding protein has a regulatory role in the coagulation system also, mediated through the beta-chain binding of protein S, a vitamin K-dependent protein that serves as a cofactor of activated protein C. The genes encoding both alpha and beta chains are located adjacent to each other on human chromosome 1 in the regulator of complement activation gene cluster. Alternative splicing gives rise to multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 1-207090484-A-G is Benign according to our data. Variant chr1-207090484-A-G is described in ClinVar as Benign. ClinVar VariationId is 402446.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.739 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001017365.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C4BPB
NM_001017365.3
MANE Select
c.232+3A>G
splice_region intron
N/ANP_001017365.1
C4BPB
NM_000716.3
c.232+3A>G
splice_region intron
N/ANP_000707.1
C4BPB
NM_001017367.1
c.232+3A>G
splice_region intron
N/ANP_001017367.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C4BPB
ENST00000367078.8
TSL:1 MANE Select
c.232+3A>G
splice_region intron
N/AENSP00000356045.3
C4BPB
ENST00000243611.9
TSL:1
c.232+3A>G
splice_region intron
N/AENSP00000243611.5
C4BPB
ENST00000367076.7
TSL:1
c.229+3A>G
splice_region intron
N/AENSP00000356043.3

Frequencies

GnomAD3 genomes
AF:
0.400
AC:
60776
AN:
151910
Hom.:
14675
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.130
Gnomad AMI
AF:
0.427
Gnomad AMR
AF:
0.465
Gnomad ASJ
AF:
0.396
Gnomad EAS
AF:
0.759
Gnomad SAS
AF:
0.545
Gnomad FIN
AF:
0.530
Gnomad MID
AF:
0.335
Gnomad NFE
AF:
0.493
Gnomad OTH
AF:
0.381
GnomAD2 exomes
AF:
0.512
AC:
122102
AN:
238584
AF XY:
0.512
show subpopulations
Gnomad AFR exome
AF:
0.127
Gnomad AMR exome
AF:
0.617
Gnomad ASJ exome
AF:
0.414
Gnomad EAS exome
AF:
0.772
Gnomad FIN exome
AF:
0.527
Gnomad NFE exome
AF:
0.495
Gnomad OTH exome
AF:
0.494
GnomAD4 exome
AF:
0.501
AC:
724115
AN:
1445818
Hom.:
186821
Cov.:
31
AF XY:
0.501
AC XY:
360444
AN XY:
719254
show subpopulations
African (AFR)
AF:
0.112
AC:
3650
AN:
32592
American (AMR)
AF:
0.600
AC:
25596
AN:
42678
Ashkenazi Jewish (ASJ)
AF:
0.412
AC:
10499
AN:
25508
East Asian (EAS)
AF:
0.766
AC:
29698
AN:
38784
South Asian (SAS)
AF:
0.534
AC:
44985
AN:
84302
European-Finnish (FIN)
AF:
0.522
AC:
27719
AN:
53114
Middle Eastern (MID)
AF:
0.321
AC:
1840
AN:
5726
European-Non Finnish (NFE)
AF:
0.500
AC:
552226
AN:
1103370
Other (OTH)
AF:
0.467
AC:
27902
AN:
59744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
15748
31497
47245
62994
78742
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16120
32240
48360
64480
80600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.400
AC:
60783
AN:
152028
Hom.:
14676
Cov.:
32
AF XY:
0.407
AC XY:
30212
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.130
AC:
5373
AN:
41486
American (AMR)
AF:
0.465
AC:
7107
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
1376
AN:
3472
East Asian (EAS)
AF:
0.759
AC:
3928
AN:
5176
South Asian (SAS)
AF:
0.546
AC:
2630
AN:
4818
European-Finnish (FIN)
AF:
0.530
AC:
5598
AN:
10560
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.493
AC:
33482
AN:
67930
Other (OTH)
AF:
0.381
AC:
803
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1614
3229
4843
6458
8072
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
582
1164
1746
2328
2910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.463
Hom.:
81896
Bravo
AF:
0.387
Asia WGS
AF:
0.613
AC:
2127
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
5.7
DANN
Benign
0.65
PhyloP100
-0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00086
dbscSNV1_RF
Benign
0.16
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6690037; hg19: chr1-207263829; COSMIC: COSV54690943; COSMIC: COSV54690943; API